Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mearns

Showing results (51-60 of 483) with videos related to

Pageof 49
Sort By:
Nature Reviews. Cardiology|April 1, 2011
Risk factors: little need to incorporate obesity measures in calculations of cardiovascular disease riskBryony M Mearns
Nature Reviews. Cardiology|June 8, 2011
Therapy: antisense inhibitor of apo B has potent lipoprotein effectsBryony M Mearns
Nature Reviews. Cardiology|November 30, 2011
Pharmacotherapy: Beneficial effects of evacetrapibBryony M Mearns
Nature Reviews. Cardiology|November 30, 2011
Atherosclerosis: Coronary effects of intensive statinsBryony M Mearns
Nature Reviews. Cardiology|February 25, 2011
Pharmacotherapy: Statins are safe in NAFLDBryony M Mearns
Nature Reviews. Cardiology|January 11, 2011
Pharmacogenetics: Ticagrelor superior to clopidogrel in individuals predicted to be clopidogrel respondersBryony M Mearns
Nature Reviews. Cardiology|June 4, 2010
Cerebral embolisms after TAVIBryony M Mearns
Nature Reviews. Cardiology|June 4, 2010
Thrombosis: a new scoring system for simple risk prediction in patients with unprovoked venous thromboembolismBryony M Mearns
Nature Reviews. Cardiology|July 27, 2010
Are you a regular passive smoker?Bryony M Mearns
Nature Reviews. Cardiology|August 4, 2010
Acute coronary syndromes: New blood tests improve risk assessment and early diagnosis of AMIBryony M Mearns
Pageof 49

Showing results (51-60 of 483) with videos related to

Sort By:
Pageof 49
Nature Reviews. Cardiology|April 1, 2011
Risk factors: little need to incorporate obesity measures in calculations of cardiovascular disease riskBryony M Mearns
Nature Reviews. Cardiology|June 8, 2011
Therapy: antisense inhibitor of apo B has potent lipoprotein effectsBryony M Mearns
Nature Reviews. Cardiology|November 30, 2011
Pharmacotherapy: Beneficial effects of evacetrapibBryony M Mearns
Nature Reviews. Cardiology|November 30, 2011
Atherosclerosis: Coronary effects of intensive statinsBryony M Mearns
Nature Reviews. Cardiology|February 25, 2011
Pharmacotherapy: Statins are safe in NAFLDBryony M Mearns
Nature Reviews. Cardiology|January 11, 2011
Pharmacogenetics: Ticagrelor superior to clopidogrel in individuals predicted to be clopidogrel respondersBryony M Mearns
Nature Reviews. Cardiology|June 4, 2010
Cerebral embolisms after TAVIBryony M Mearns
Nature Reviews. Cardiology|June 4, 2010
Thrombosis: a new scoring system for simple risk prediction in patients with unprovoked venous thromboembolismBryony M Mearns
Nature Reviews. Cardiology|July 27, 2010
Are you a regular passive smoker?Bryony M Mearns
Nature Reviews. Cardiology|August 4, 2010
Acute coronary syndromes: New blood tests improve risk assessment and early diagnosis of AMIBryony M Mearns
Pageof 49